![PDF] Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases. | Semantic Scholar PDF] Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/67c96da6b9aa4779eb1ad7a0b46025ffae55317b/2-Figure1-1.png)
PDF] Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases. | Semantic Scholar
![Retrospective analysis of the association between human epidermal growth factor receptor 2 amplification and chromosome enumeration probe 17 status in patients with breast cancer Retrospective analysis of the association between human epidermal growth factor receptor 2 amplification and chromosome enumeration probe 17 status in patients with breast cancer](https://www.spandidos-publications.com/article_images/ol/14/5/ol-14-05-5265-g03.jpg)
Retrospective analysis of the association between human epidermal growth factor receptor 2 amplification and chromosome enumeration probe 17 status in patients with breast cancer
![Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-6562-g01.jpg)
Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome
![Biology | Free Full-Text | A Reliable and Standardizable Differential PCR and qPCR Methodology Assesses HER2 Gene Amplification in Gastric Cancer Biology | Free Full-Text | A Reliable and Standardizable Differential PCR and qPCR Methodology Assesses HER2 Gene Amplification in Gastric Cancer](https://www.mdpi.com/biology/biology-10-00516/article_deploy/html/images/biology-10-00516-g001.png)
Biology | Free Full-Text | A Reliable and Standardizable Differential PCR and qPCR Methodology Assesses HER2 Gene Amplification in Gastric Cancer
![AstraZeneca on Twitter: "Approx. 20-30% of #breastcancer have a faulty HER2 gene which makes too many copies of itself – this is known as gene amplification. This results in more HER2 receptors AstraZeneca on Twitter: "Approx. 20-30% of #breastcancer have a faulty HER2 gene which makes too many copies of itself – this is known as gene amplification. This results in more HER2 receptors](https://pbs.twimg.com/media/ELmJtymVAAEJpCe.png:large)
AstraZeneca on Twitter: "Approx. 20-30% of #breastcancer have a faulty HER2 gene which makes too many copies of itself – this is known as gene amplification. This results in more HER2 receptors
![Diagnostic de l'amplification du gène HER2 dans les cancers du sein: Le point de vue génétique - ScienceDirect Diagnostic de l'amplification du gène HER2 dans les cancers du sein: Le point de vue génétique - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0369811408000552-gr1.jpg)
Diagnostic de l'amplification du gène HER2 dans les cancers du sein: Le point de vue génétique - ScienceDirect
![HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray–Fluorescence In Situ Hydridization–Based Study - Luisa Vera Muscatello, Enrico Di Oto, Giuseppe Sarli, Valentina Monti, Maria Pia Foschini, Cinzia Benazzi, Barbara Brunetti, HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray–Fluorescence In Situ Hydridization–Based Study - Luisa Vera Muscatello, Enrico Di Oto, Giuseppe Sarli, Valentina Monti, Maria Pia Foschini, Cinzia Benazzi, Barbara Brunetti,](https://journals.sagepub.com/cms/10.1177/0300985818808531/asset/images/large/10.1177_0300985818808531-fig2.jpeg)
HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray–Fluorescence In Situ Hydridization–Based Study - Luisa Vera Muscatello, Enrico Di Oto, Giuseppe Sarli, Valentina Monti, Maria Pia Foschini, Cinzia Benazzi, Barbara Brunetti,
![Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | SpringerLink Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12094-019-02213-9/MediaObjects/12094_2019_2213_Fig1_HTML.png)
Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | SpringerLink
HER2 amplification in a tumor sample from a patient with extramammary... | Download Scientific Diagram
![Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-44643-z/MediaObjects/41598_2019_44643_Fig1_HTML.png)
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports
![Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer - ScienceDirect Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721001364-fx1.jpg)
Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer - ScienceDirect
![Frontiers | HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies Frontiers | HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies](https://www.frontiersin.org/files/Articles/860313/fonc-12-860313-HTML/image_m/fonc-12-860313-g001.jpg)
Frontiers | HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies
![Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer](https://www.frontiersin.org/files/Articles/834651/fmolb-09-834651-HTML/image_m/fmolb-09-834651-g001.jpg)
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
![Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-44643-z/MediaObjects/41598_2019_44643_Fig4_HTML.png)
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports
![The assessment of HER2 status in breast cancer: the past, the present, and the future - Nitta - 2016 - Pathology International - Wiley Online Library The assessment of HER2 status in breast cancer: the past, the present, and the future - Nitta - 2016 - Pathology International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a4bc0b40-da17-437b-8412-9c53410604bf/pin12407-fig-0001-m.jpg)
The assessment of HER2 status in breast cancer: the past, the present, and the future - Nitta - 2016 - Pathology International - Wiley Online Library
![Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications](https://static.hindawi.com/articles/mbi/volume-2014/852748/figures/852748.fig.002d.jpg)